Læknablaðið - 01.04.2014, Blaðsíða 23

LÆKNAblaðið 2014/100 223
Heimildir
1. Gottrup F, Jørgensen B, Karlsmark T. News in wound
healing and management. Curr Opin Support Palliat Care
2009; 3: 300-4.
2. Gottrup F, Holstein P, Jorgensen B, Lohmann M, Karlsmar
T. A new concept of a wound healing center and a national
expert function of wound healing. Arch Surg 2001; 136:
765-72.
3. Argenta LC, Morykwas MJ. Vacuum-assisted closure: a
new method for wound control and treatment: clinical
experience. Ann Plast Surg 1997; 386: 563-7; discussion 77.
4. Blume PA, Walters J, Payne W, Ayala J, Lantis J.
Comparison of negative pressure wound therapy using
vacuum-assisted closure with advanced moist wound the-
rapy in the treatment of diabetic foot ulcers: a multicenter
randomized controlled trial. Diabetes Care 2008; 31: 631-6.
5. Braakenburg A, Obdeijn MC, Feitz R, van Rooij IA, van
Griethuysen AJ, Klinkenbijl JH. The clinical efficacy and
cost effectiveness of the vacuum-assisted closure techni-
que in the management of acute and chronic wounds: a
randomized controlled trial. Plast Reconstr Surg 2006; 118:
390-7; discussion 8-400.
6. Llanos S, Danilla S, Barraza C, Armijo E, Piñeros JL,
Quintas M, et al. Effectiveness of negative pressure closure
in the integration of split thickness skin grafts: a randomi-
zed, double-masked, controlled trial. Ann Surg 2006; 244:
700-5.
7. Vuerstaek JD, Vainas T, Wuite J, Nelemans P, Neumann
MH, Veraart JC. State-of-the-art treatment of chronic leg
ulcers: A randomized controlled trial comparing vacuum-
assisted closure (V.A.C.) with modern wound dressings. J
Vasc Surg 2006; 44: 1029-37; discussion 38.
8. Armstrong DG, Lavery LA, Consortium DFS. Negative
pressure wound therapy after partial diabetic foot
amputation: a multicentre, randomised controlled trial.
Lancet 2005; 366: 1704-10.
9. DeFranzo AJ, Pitzer K, Molnar JA, Marks MW, Chang MC,
Miller PR, et al. Vacuum-assisted closure for defects of the
abdominal wall. Plast Reconstr Surg 2008; 121: 832-9.
10. Petzina R, Hoffmann J, Navasardyan A, Malmsjo
M, Stamm C, Unbehaun A, et al. Negative pressure
wound therapy for post-sternotomy mediastinitis reduces
mortality rate and sternal re-infection rate compared to
conventional treatment. Eur J Cardiothorac Surg 2010; 38:
110-3.
11. Bloemen MC, van der Wal MB, Verhaegen PD,
Nieuwenhuis MK, van Baar ME, van Zuijlen PP, et al.
Clinical effectiveness of dermal substitution in burns
by topical negative pressure: a multicenter randomized
controlled trial. Wound Repair Regen 2012; 20: 797-805.
12. Armstrong D, Lavery L. Negative pressure wound therapy
after partial diabetic foot amputation: a multicentre,
randomised controlled trial. Lancet 2005; 366: 1704-10.
13. Chariker M, Jeter K, Tintle T, Ottsford J. Effective manage-
ment of incisional and cutaneous fistulae with closed
suction wound drainage. Contemporary Surgery 1989; 34:
59-63.
14. Fleischmann W, Strecker W, Bombelli M, Kinzl L. [Vacuum
sealing as treatment of soft tissue damage in open fract-
ures]. Unfallchirurg 1993; 96/99: 488-92.
15. Malmsjö M, Ingemansson R, Sjögren J. Mechanisms
governing the effects of vacuum-assisted closure in cardiac
surgery. Plast Reconstr Surg 2007; 120: 1266-75.
16. Malmsjö M, Ingemansson R, Martin R, Huddleston E.
Negative-pressure wound using gauze or open-cell
polyurethane foam: similar early effects on pressure trans-
duction and tissue contraction in an experimental porcine
wound model. Wound Repair Regen 2009; 17: 200-5.
17. Birke-Sorensen H, Malmsjo M, Rome P, Hudson D, Krug
E, Berg L, et al. Evidence-based recommendations for
negative pressure wound therapy: Treatment variables
(pressure levels, wound filler and contact layer) – Steps
towards an international consensus. J Plast Reconstr
Aesthet Surg 2011; 64, Supplement S1-S16.
18. Borgquist O, Anesäter E, Hedström E, Lee CK,
Ingemansson R, Malmsjö M. Measurements of wound
edge microvascular blood flow during negative pressure
wound therapy using thermodiffusion and transcutaneo-
us and invasive laser Doppler velocimetry. Wound Repair
Regen 2011; 19: 727-33.
19. Malmsjö M, Ingemansson R, Martin R, Huddleston E.
Wound edge microvascular blood flow: effects of negative
pressure wound therapy using gauze or polyurethane
foam. Ann Plast Surg 2009; 63: 676-81.
20. Malmsjo M, Ingemansson R. Effects of green foam, black
foam and gauze on contraction, blood flow and pressure
delivery to the wound bed in negative pressure wound
therapy. J Plast Reconstr Aesthet Surg 2011; 64 : e289-96.
21. Dorafshar AH, Franczyk M, Gottlieb LJ, Wroblewski KE,
Lohman RF. A prospective randomized trial comparing
subatmospheric wound therapy with a sealed gauze dress-
ing and the standard vacuum-assisted closure device. Ann
Plast Surg 2012; 69: 79-84.
22. Albert NM, Rock R, Sammon MA, Bena JF, Morrison SL,
Whitman A, et al. Do patient and nurse outcome differen-
ces exist between 2 negative pressure wound therapy sys-
tems? J Wound Ostomy Continence Nurs 2012; 39: 259-66.
23. Borgquist O, Gustafsson L, Ingemansson R, Malmsjö M.
Micro- and macromechanical effects on the wound bed of
negative pressure wound therapy using gauze and foam.
Ann Plast Surg 2010; 64: 789-93.
24. Hudson DA, Adams KG, Huyssteen AV, Martin R,
Huddleston EM. Simplified negative pressure wound
therapy: clinical evaluation of an ultraportable, no-canister
system. Int Wound J 2013. doi: 10.1111/iwj.12080
25. Malmsjö M, Borgquist O. NPWT setting and dressing
choices. Wounds Int 2010; 1: 1-6.
26. Sjögren J, Malmsjö M, Gustafsson R, Ingemansson R.
Poststernotomy mediastinitis: a review of conventional
surgical treatments, vacuum-assisted closure therapy and
presentation of the Lund University Hospital mediastinitis
algorithm. Eur J Cardiothorac Surg 2006; 30: 898-905.
27. Malmsjö M, Gustafsson L, Lindstedt S, Gesslein B,
Ingemansson R. The effects of variable, intermittent,
and continuous negative pressure wound therapy, using
foam or gauze, on wound contraction, granulation tissue
formation, and ingrowth into the wound filler. Eplasty
2012; 12: e5.
28. Obdeijn MC, de Lange MY, Lichtendahl DHE, de Boer WJ.
Vacuum-assisted closure in the treatment of poststerno-
tomy mediastinitis. Ann Thorac Surg 1999; 68: 2358-60.
29. Yu AW, Rippel RA, Smock E, Jarral OA. In patients with
post-sternotomy mediastinitis is vacuum-assisted closure
superior to conventional therapy? Interact Cardiovasc
Thorac Surg 2013; 17: 861-5.
30. Berg TC, Kjørstad KE, Akselsen PE, Seim BE, Løwer
HL, Stenvik MN, et al. National surveillance of surgical
site infections after coronary artery bypass grafting in
Norway: incidence and risk factors. Eur J Cardiothorac
Surg 2011; 40: 1291-7.
31. El Oakley RM, Wright JE. Postoperative mediastinitis:
classification and management. Ann Thorac Surg 1996; 61:
1030-6.
32. Manniën J, Wille JC, Kloek JJ, van Benthem BH.
Surveillance and epidemiology of surgical site infections
after cardiothoracic surgery in The Netherlands, 2002-
2007. J Thorac Cardiovasc Surg 2011; 141: 899-904.
33. Hallgrímsdóttir H, Kristjánsdóttir Á, Guðbjartsson T.
Framsýn gæðarannsókn á tíðni skurðsýkinga eftir opnar
hjartaaðgerðir. Læknablaðið 2013; 99/fylgirit 76: 26.
34. Steingrimsson S, Gottfredsson M, Kristinsson KG,
Gudbjartsson T. Deep sternal wound infections following
open heart surgery in Iceland: a population-based study.
Scand Cardiovasc J 2008; 42: 208-13.
35. Alasmari FA, Tleyjeh IM, Riaz M, Greason KL, Berbari EF,
Virk A, et al. Temporal trends in the incidence of surgical
site infections in patients undergoing coronary artery
bypass graft surgery: a population-based cohort study,
1993 to 2008. Mayo Clin Proc 2012; 87: 1054-61.
36. Jidéus L, Liss A, Ståhle E. Patients with sternal wound
infection after cardiac surgery do not improve their quality
of life. Scand Cardiovasc J 2009; 43: 194-200.
37. Steingrimsson S, Gottfredsson M, Gudmundsdottir I,
Sjögren J, Gudbjartsson T. Negative-pressure wound
therapy for deep sternal wound infections reduces the rate
of surgical interventions for early re-infections. Interact
Cardiovasc Thorac Surg 2012; 15: 406-10.
R A N N S Ó K N
heildartími sem fer í sáraskiptingar er marktækt styttri.5, 68 Þetta
er ótvíræður kostur, ekki síst þegar meðferðinni er beitt í heima-
hjúkrun.67
Sárasogsmeðferð hérlendis
Sárasogsmeðferð hefur verið notuð á Íslandi í rúman áratug og
notkun hennar fer stöðugt vaxandi, sérstaklega innan almennra
skurðlækninga. Brjóstholsskurðlæknar og lýtalæknar hafa notað
meðferðina mest en einnig æðaskurðlæknar í vaxandi mæli. Í ný-
legri grein í Læknablaðinu var farið yfir notkun sárasogsmeðferðar
hér á landi á 12 mánuða tímabili árið 2008, bæði innan sjúkrahúsa
og utan.69 Á þessu 12 mánaða tímabili fengu 56 sjúklingar samtals
65 meðferðir. Oftast var meðferðinni beitt við sýkt skurðsár (40%)
og til að örva gróanda (42%). Fullur gróandi náðist í 68% meðferða
sem telst mjög góður árangur,69 en samkvæmt erlendum rann-
sóknum næst gróandi í 29-39% sára með hefðbundinni sárasogs-
meðferð.4,12 Auk þess hefur sárasogsmeðferð verið töluvert rann-
sökuð við sýkingar í bringubeinsskurði eftir opnar hjartaaðgerðir
hér á landi. Hefur árangur verið mjög góður og á við það besta sem
þekkist erlendis.3.7
Sárasogsmeðferð er mikilvæg nýjung í sárameðferð sem helst
nýtist sjúklingum með langvinn sár og sýkt skurðsár. Mikilvægt
er að læknar og hjúkrunafræðingar þekki til helstu ábendinga og
frábendinga meðferðarinnar, enda hefur notkun sárasogsmeð-
ferðar farið hratt vaxandi víða um heim.
Þakkir
Þakkir fær Þorkell Jóhannesson ljósmyndari fyrir aðstoð við
gerð ljósmynda, Þórunn Edda Bjarnadóttir og Guðrún Berglind
Sigurðardóttir fyrir myndvinnslu og Sigfríður Guðjónsdóttir fyrir
yfirlestur handrits og ábendingar.